Добавил:
Upload Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Color Atlas of Physiology 2003 thieme

.pdf
Скачиваний:
113
Добавлен:
15.02.2016
Размер:
36.12 Mб
Скачать

A. Bile components and hepatic

B. Enterohepatic circulation of bile salts

secretion of bile

 

 

Cholesterol

Primary

 

bile salts

 

 

Cholesterol

 

 

 

Secondary

Liver

From

 

bile salts

Taurine

enterohepatic

 

Synthesis

circulation

 

Glycine

 

 

 

 

Portal vein

 

 

Bile salts

Lecithin

Conjugated

 

 

 

 

bile salts

 

 

 

 

 

 

 

 

 

 

 

Biliary canaliculi

 

Bile salt pool (2–4g)

 

 

 

 

circulates

 

 

 

 

Inorganic

 

 

 

 

6–10 times a day

 

Sinusoid

 

 

electrolytes

 

Secondary-

 

 

 

H2O

Common

Bile

 

 

 

active

 

 

 

Alkaline

bile duct

Na+

 

 

 

phosphatase

 

symport

10.12

 

 

 

 

 

Small intestine

 

 

 

 

(terminal ileum)

 

 

 

 

 

 

Drugs

Glutathione

 

 

 

Plate

 

 

 

 

 

 

 

Glucuronic

 

 

 

Hormones

 

Hepatocyte

 

 

 

 

acid

 

 

 

 

 

 

 

 

 

Excretion

 

Bilirubin

 

 

Conjugation

 

(0.6g/day)

 

 

 

 

 

 

C. Bile flow

 

 

 

 

 

 

 

 

 

 

 

Bile salt-

 

Bile flow

 

 

 

 

dependent

 

 

 

 

Hepatocytes

Bile salt-

 

 

0

 

 

Bile ducts

independent

 

 

 

 

 

 

 

Concentration of bile salts in plasma

 

 

 

 

 

 

D. Gallbladder

 

H2O Na+

Vagus nerve

 

Cl

 

C bile

 

B bile

1

 

 

 

ACh

Fats

 

 

 

2

Fatty acids

 

 

 

CCK

 

E. Micelle-mediated “dissolution”

 

 

of cholesterol in the bile

 

 

 

 

 

 

 

 

 

100

Separation:

 

 

 

 

 

 

 

 

 

cholesterol crystals

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(

 

 

 

 

 

 

 

 

mol)

80

20

pho

 

 

 

 

 

 

 

 

 

s

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(%

 

 

 

L

 

 

 

 

 

 

 

 

 

ph

 

 

 

 

 

 

 

 

 

 

ec

 

 

 

 

 

 

 

 

40

a

 

 

 

 

 

 

 

60

 

 

 

 

 

 

 

 

 

(%

 

 

 

 

 

 

 

 

ithin

 

 

 

 

e

r

ol

 

 

 

 

 

 

 

 

 

mol)

 

 

 

Chole

st

 

 

 

 

 

 

tidylcholine

 

 

 

 

40

 

 

 

 

 

 

 

 

 

 

 

 

 

60

 

 

 

 

 

 

 

 

 

 

Micelle-

)

 

 

 

 

 

 

 

 

 

 

al.)

 

20

 

 

 

 

 

 

 

 

 

 

 

 

mediated

 

 

 

 

 

 

 

 

 

“dissolution”

et

 

 

 

 

 

 

 

 

 

Small

 

0

 

 

 

 

80

60

40

 

20

100

249

100

 

 

 

 

0

(After

 

 

 

 

 

 

Bile salts (%mol)

 

 

 

 

Despopoulos, Color Atlas of Physiology © 2003 Thieme

All rights reserved. Usage subject to terms and conditions of license.

Excretory Liver Function—Bilirubin

 

The liver detoxifies and excretes many mostly

 

lipophilic substances, which are either

 

generated during metabolism (e.g., bilirubin or

 

steroid hormones) or come from the intestinal

 

tract (e.g., the antibiotic chloramphenicol).

 

However, this requires prior biotransforma-

 

tion of the substances. In the first step of the

 

process, reactive OH, NH2 or COOH groups are

 

enzymatically added (e.g., by monooxy-

Digestion

genases) to the hydrophobic substances. In the

second step, the substances are conjugated

 

 

with glucuronic acid, acetate, glutathione, gly-

 

cine, sulfates, etc. The conjugates are now

and

water-soluble and can be

either further

processed in the kidneys and excreted in the

 

Nutrition10

urine, or secreted into bile by liver cells and ex-

Carriers. The canalicular membrane of hepatocytes

 

creted in the feces. Glutathione conjugates, for

 

example, are further processed in the kidney

 

excreted as mercapturic acids in the urine.

 

contains various carriers, most of which are directly

 

fueled by ATP (see also p. 248). The principal carriers

 

are: MDR1 (multidrug resistance protein 1) for rela-

 

tively hydrophobic, mainly cationic metabolites,

 

MDR3 for phosphatidylcholine

(!p. 248), and

 

cMOAT (canalicular multispecific organic anion

 

transporter = multidrug resistance protein MRP2) for

 

conjugates (formed with glutathione, glucuronic

 

acid or sulfate) and many other organic anions.

 

Bilirubin sources and conjugation. Ca. 85% of

 

all bilirubin originates from the hemoglobin in

 

erythrocytes; the rest is produced by other

 

hemoproteins like cytochrome (!A and B).

 

When degraded, the globulin and iron com-

 

ponents (!p. 90) are cleaved from hemoglo-

 

bin. Via intermediate steps, biliverdin and fi-

 

nally bilirubin, the yellow bile pigment, are

 

then formed from the porphyrin residue. Each

 

gram of hemoglobin yields ca. 35 mg of biliru-

 

bin. Free unconjugated bilirubin (“indirect”

 

bilirubin) is poorly soluble in water, yet lipid-

 

soluble and toxic. It is therefore complexed

 

with albumin when present in the blood (2 mol

 

bilirubin : 1 mol albumin), but not when ab-

 

sorbed by hepatocytes (!A). Bilirubin is con-

 

jugated (catalyzed by glucuronyltransferase)

 

with 2 molecules of UDP-glucuronate (synthe-

250

sized from glucose, ATP and UTP) in the liver

cells yielding bilirubin diglucuronide (“direct”

bilirubin). It is a water-soluble substance secreted into the biliary canaliculi by primary active transport mechanisms (cMOAT, see above).

Bilirubin excretion. 200–250 mg of bilirubin is excreted in the bile each day. Ca. 90% of it is excreted in the feces. In the gut, bacteria break bilirubin down into the colorless compound, stercobilinogen (!B). It is partly oxidized into stercobilin, the brown compound that colors the stools. About 10% of all bilirubin diglucuronide is deconjugated by intestinal bacteria and returned to the liver in this lipophilic form (partly as stercobilinogen) via enterohepatic circulation. A small portion (ca. 1%) reaches the systemic circulation and is excreted by the kidneys as urobilinogen = stercobilinogen (see below) (!B). The renal excretion rate increases when the liver is damaged.

Jaundice. The plasma bilirubin concentration normally does not exceed 17 µmol/L (= 1 mg/dL). Concentrations higher than 30 µmol/L (1.8 mg/dL) lead to yellowish discoloration of the sclera and skin, resulting in jaundice (icterus). Types of jaundice:

1.Prehepatic jaundice. When excessive amounts of bilirubin are formed, for example, due to increased hemolysis, the liver can no longer cope with the higher load unless the plasma bilirubin concentration rises. Thus, unconjugated (indirect) bilirubin is mainly elevated in these patients.

2.Intrahepatic jaundice. The main causes are (a) liver cell damage due to toxins (Amanita) or infections (viral hepatitis) resulting in the impairment of bilirubin transport and conjugation; (b) deficiency or absence of the glucuronyltransferase system in the newborn (Crigler–Najjar syndrome); (c) inhibition of glucuronyltransferase, e.g., by steroids; (d) impaired secretion of bilirubin into the biliary canaliculi due to a congenital defect (Dubin–Johnson syndrome) or other reasons (e.g., drugs, steroid hormones).

3.Posthepatic jaundice: Impairment of the flow of bile occurs due to an obstruction (e.g., stone or tumor) in the bile ducts, usually accompanied by elevated serum concentrations of conjugated (direct) bilirubin and alkaline phosphatase—both of which are normal components of bile.

Types 2a, 2d and 3 jaundice are associated with increased urinary concentrations of conjugated bilirubin, leading to brownish discoloration of the urine. In type 3 jaundice, the stools are gray due to the lack of bilirubin in the intestine and the resulting absence of stercobilin formation.

Despopoulos, Color Atlas of Physiology © 2003 Thieme

All rights reserved. Usage subject to terms and conditions of license.

A. Conjugation and secretion of bilirubin in the liver

Albumin

 

 

cMOAT

 

 

 

Bilirubin-

Function—Bilirubin

 

Bilirubin

Glucuronyl-

 

digluc-

 

Bilirubin

transferase

 

uronide

 

 

 

 

 

 

ATP

 

UDP-

 

Biliary

 

glucuronic

 

acid

 

canaliculi

Albumin

UTP

 

UDP

 

 

 

Glucose

 

 

Liver

 

 

 

 

 

Blood

Hepatocyte

 

Excretory

B. Bilirubin metabolism and excretion

 

 

 

 

 

 

 

Blood

Bilirubin

 

10.13

Hb

230

 

 

 

6.5

 

mg/day

 

g/day

 

 

 

Plate

 

Macro-

 

 

 

phages

 

 

 

 

 

 

 

Conjugation

 

 

 

(glucuronyltransferase)

 

 

Other

 

 

 

 

sources

 

Bile

1 5 %

 

 

Liver

 

enterohepatic

 

 

Bilirubin

circulation

 

 

 

 

 

 

diglucuronide

 

 

 

Large intestine

 

 

 

 

 

Bilirubin

Urobilinogen

 

Greater

 

 

 

 

circulation

 

 

 

 

 

 

Sterco-

 

 

Small intestine

bilinogen

 

 

 

 

 

 

 

Stercobilin

 

 

Kidney

 

Urobilin

 

 

 

 

 

 

 

= Anaerobic

 

 

 

 

bacteria

 

 

 

1 %

= O2

 

 

 

 

85 %

251

 

in urine

 

 

 

in feces

 

(urobilin, etc.)

 

 

 

 

 

 

Despopoulos, Color Atlas of Physiology © 2003 Thieme

All rights reserved. Usage subject to terms and conditions of license.

Lipid Digestion

 

The average intake of fats (butter, oil, mar-

 

garine, milk, meat, sausages, eggs, nuts etc.) is

 

roughly 60–100 g/day, but there is a wide

 

range of individual variation (10–250 g/day).

 

Most fats in the diet (90%) are neutral fats or

 

triacylglycerols (triglycerides). The rest are

 

phospholipids, cholesterol esters, and fat-

 

soluble vitamins (vitamins A, D, E and K). Over

 

95% of the lipids are normally absorbed in the

Digestion

small intestine.

Lipid digestion (!A). Lipids are poorly

 

 

soluble in water, so special mechanisms are re-

 

quired for their digestion in the watery en-

and

vironment of the gastrointestinal tract and for

their subsequent absorption and transport in

Nutrition

plasma (!p. 254). Although small quantities

before they can be efficiently absorbed. Opti-

 

of undegraded triacylglycerol can be absorbed,

 

dietary fats must be hydrolyzed by enzymes

10

mal enzymatic activity requires the prior me-

chanical emulsification of fats (mainly in the

 

 

distal stomach, !p. 240) because emulsified

 

lipid droplets (1–2 µm; !B1) provide a much

 

larger surface (relative to the mass of fat) for

 

lipases.

 

Lipases, the fat digesting enzymes, originate

 

from the lingual glands, gastric fundus (chief

 

and mucous neck cells) and pancreas (!A and

 

p. 246). About 10–30% of dietary fat intake is

 

hydrolyzed in the stomach, while the remain-

 

ing 70–90% is broken down in the duodenum

 

and upper jejunum. Lingual and gastric lipases

 

have an acid pH optimum, whereas pancreatic

 

lipase has a pH optimum of 7–8. Lipases be-

 

come active at the fat/oil and water interface

 

(!B). Pancreatic lipase (triacylglycerol hy-

 

drolase) develops its lipolytic activity (max.

 

140 g fat/min) in the presence of colipase and

 

Ca2+. Pro-colipase in pancreatic juice yields

 

colipase after being activated by trypsin. In

 

most cases, the pancreatic lipases split triacyl-

 

glycerol (TG) at the 1st and 3rd ester bond. This

 

process requires the addition of water and

 

yields free fatty acids (FFA) and 2-monoacyl-

 

glycerol.

A viscous-isotropic phase with aqueous and hydrophobic zones then forms around the enzyme (!B2).

252Ca2+ excesses or monoacylglycerol deficiencies result in the conversion of the fatty acids into calcium soaps,

which are later excreted.

Phospholipase A2 (from pro-phospholipase A2 in pancreatic juice—activated by trypsin) cleaves the 2nd ester bond of the phospholipids (mainly phosphatidylcholine = lecithin) contained in micelles. The presence of bile salts and Ca2+ is required for this reaction.

An unspecific carboxylesterase (= unspecific lipase = cholesterol ester hydrolase) in pancreatic secretions also acts on cholesterol esters on micelles as well as all three ester bonds of TG and esters of vitamins, A, D and E.

This lipase is also present in human breast milk (but not cow’s milk), so breast-fed infants receive the digestive enzyme required to break down milk fat along with the milk. Since the enzyme is heat-sensi- tive, pasteurization of human milk significantly reduces the infant’s ability to digest milk fat to a great extent.

2-Monoacylglycerols, long-chain free fatty acids and other lipids aggregate with bile salts (!p. 248) to spontaneously form micelles in the small intestine (!B3). (Since short-chain fatty acids are relatively polar, they can be absorbed directly and do not require bile salts or micelles). The micelles are only about 20–50 nm in diameter, and their surface-to- volume ratio is roughly 50 times larger than that of the lipid droplets in emulsions. They facilitate close contact between the products of fat digestion and the wall of the small intestine and are therefore essential for lipid absorption. The polar side of the substances involved (mainly conjugated bile salts, 2-mono- acylglycerol and phospholipids) faces the watery environment, and the non-polar side faces the interior of the micelle. Totally apolar lipids (e.g., cholesterol esters, fat-soluble vitamins and lipophilic poisons) are located inside the micelles. Thus, the apolar lipids remain in the lipophilic milieu (hydrocarbon continuum) during all these processes until they reach the lipophilic brush border membrane of the epithelium. They are then absorbed by the mucosa cells via dissolution in the membrane or by a passive transport mechanism (e.g., carriers in the case of free fatty acids). Although fat absorption is completed by the time the chyme reaches the end of the jejunum, the bile salts released from micelles are only absorbed in the terminal ileum and then recycled (enterohepatic circulation; !p. 249 B).

Despopoulos, Color Atlas of Physiology © 2003 Thieme

All rights reserved. Usage subject to terms and conditions of license.

A. Lipid digestion: overview

 

Dietary fats

Stomach

 

 

Mechanical emulsifi-

Lipases from

stomach and

cation by stomach

tongue

 

 

Degradation in

Bile salts

 

 

 

stomach (10–30%)

 

Pancreatic lipase

 

 

 

Pancreas

 

 

Duodenum

 

 

 

Digestion

Degradation and micelle

 

 

Excreted as

formation in duodenum and

 

 

calcium soaps

 

jejunum (70–95%)

Absorption in intestine

(ca. 5%)

Lipid

 

 

 

 

 

B. Lipid digestion: degradation and micelle formation

 

 

10.14

 

 

Emulsification

 

Stomach

 

 

 

Plate

 

 

 

1–2 m

 

 

 

 

 

 

 

 

1 Oil phase

Emulsified

 

 

 

 

 

 

 

 

TG

 

triacylglycerols

 

 

 

and other

 

 

 

 

 

lipids

 

 

 

 

 

Chyme

 

 

 

Lipase

 

 

 

 

MG+FFA

H2O

 

 

 

 

 

 

 

20–50nm

 

 

 

BS

 

 

 

 

2 Viscous–isotropic phase

 

 

 

 

 

Triacylglycerol (TG)

 

 

 

 

 

2-Monoacylglycerol (MG)

 

Micelles

 

 

 

 

 

 

 

 

Free fatty acids (FFA)

 

Mucosal cell

 

 

 

Apolar lipids

 

 

 

 

 

 

 

253

 

Bile salts (BS)

3

Micelle phase

 

 

(After Patton)

 

 

 

 

Despopoulos, Color Atlas of Physiology © 2003 Thieme

All rights reserved. Usage subject to terms and conditions of license.

10 Nutrition and Digestion

254

Lipid Distribution and Storage

High-density lipoproteins (HDL) exchange

certain apoproteins with chylomicrons and

Lipids in the blood are transported in lipo-

VLDL and absorb superfluous CHO from the

proteins, LPs (!A), which are molecular

extrahepatic cells and blood (!B). With their

aggregates (microemulsions) with a core of

ApoAI, they activate the plasma enzyme LCAT

very hydrophobic lipids such as triacylglycerols

(lecithin–cholesterol acyltransferase), which

(TG) and cholesterol esters (CHO-esters) sur-

is responsible for the partial esterification of

rounded by a layer of amphipathic lipids

CHO. HDL also deliver cholesterol and CHO-

(phospholipids, cholesterol). LPs also contain

esters to the liver and steroid hormone-pro-

several types of proteins, called apolipo-

ducing glands with HDL receptors (ovaries,

proteins. LPs are differentiated according to

testes, adrenal cortex).

their size, density, lipid composition, site of

 

synthesis, and their apolipoprotein content.

Triacylglycerol (TG)

Apolipoproteins (Apo) function as structural

Dietary TGs are broken down into free fatty

elements of LPs (e.g. ApoAII and ApoB48), lig-

acids (FFA) and 2-monoacylglycerol (MG) in the

ands (ApoB100, ApoE, etc.) for LP receptors on

gastrointestinal tract (!C and p. 252). Since

the membranes of LP target cells, and as

short-chain FFAs are water-soluble, they can

enzyme activators (e.g. ApoAI and ApoCII).

be absorbed and transported to the liver via

Chylomicrons transport lipids (mainly tri-

the portal vein. Long-chain FFAs and 2-mono-

acylglycerol, TG) from the gut to the periphery

acylglycerols are not soluble in water. They are

(via intestinal lymph and systemic circulation;

re-synthesized to TG in the mucosa cells (!C).

!D), where their ApoCII activates endothelial

(The FFAs needed for TG synthesis are carried

lipoprotein lipase (LPL), which cleaves FFA

by FFA-binding proteins from the cell mem-

from TG. The FFA are mainly absorbed by myo-

brane to their site of synthesis, i.e., the smooth

cytes and fat cells (!D). With the aid of ApoE,

endoplasmic reticulum.) Since TGs are not

the chylomicron remnants deliver the rest of

soluble in water, they are subsequently loaded

their TG, cholesterol and cholesterol ester load

onto chylomicrons, which are exocytosed into

to the hepatocytes by receptor-mediated en-

the extracellular fluid, then passed on to the

docytosis (!B, D).

intestinal lymph (thereby by-passing the

Cholesterol (CHO) and the TG imported

liver), from which they finally reach the

from the gut and newly synthesized in the liver

greater circulation (!C, D). (Plasma becomes

are exported inside VLDL (very low density

cloudy for about 20–30 minutes after a fatty

lipoproteins) from the liver to the periphery,

meal due to its chylomicron content). The liver

where they by means of their ApoCII also acti-

also synthesizes TGs, thereby taking the re-

vate LPL, resulting in the release of FFA (!D).

quired FFAs from the plasma or synthesizing

This results in the loss of ApoCII and exposure

them from glucose. Hepatic TGs are loaded

of ApoE. VLDL remnants or IDL (intermediate-

onto VLDL (see above) and subsequently

density lipoproteins) remain. Ca. 50% of the IDL

secreted into the plasma (!D). Since the ex-

returns to the liver (mainly bound by its ApoE

port capacity of this mechanism is limited, an

on LDL receptors; see below) and is re-

excess of FFA or glucose (!D) can result in the

processed and exported from the liver as VLDL

accumulation of TGs in the liver (fatty liver).

(!B).

Free fatty acids (FFAs) are high-energy sub-

The other 50% of the IDL is converted to LDL

strates used for energy metabolism (!p. 228).

(low density lipoprotein) after coming in con-

Fatty acids circulating in the blood are mainly

tact with hepatic lipase (resulting in loss of

transported in the form of TG (in lipoproteins)

ApoE and exposure of ApoB100). Two-thirds of

whereas plasma FFA are complexed with al-

the LDLs deliver their CHO and CHO-esters to

bumin. Fatty acids are removed from TGs of

the liver, the other third transfers its CHO to

chylomicrons and VLDL by lipoprotein lipase

extrahepatic tissue (!B). Binding of ApoB100

(LPL) localized on the luminal surface of the

to LDL receptors is essential for both processes

capillary endothelium of many organs (mainly

(see below).

in fat tissue and muscles) (!D). ApoCII on the

 

!

Despopoulos, Color Atlas of Physiology © 2003 Thieme

All rights reserved. Usage subject to terms and conditions of license.

A. Lipoproteins

Triacylglycerols

Chylomicrons

VLDL

LDL

 

HDL

 

 

 

 

 

0.08

 

 

 

 

Cholesterol

 

 

 

 

 

 

 

 

 

 

 

0.12

 

 

 

 

 

esters

0.86 g/g

 

 

 

 

 

 

 

0.07

0.22

 

0.30

 

 

Cholesterol

 

 

0.55

 

I

 

 

 

0.18

0.42

 

0.47

Storage

 

 

 

 

 

0.22

 

 

Phospholipids

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.03

 

 

 

 

0.04

 

 

 

 

 

0.06

 

 

Proteins

 

0.02

 

0.08

 

0.15

 

0.02

 

 

and

 

 

0.07

 

 

 

 

0.04

 

Diameter

80–500nm

ca. 50nm

ca. 20nm

 

ca. 10nm

 

 

Distribution

Apolipoproteins

AI, B48, CII+III, E

B100, CII+III, E

B100, CIII, E AI,III+IV, CIII, D

B. Sources and fate of cholesterol

 

 

 

 

 

 

 

 

 

 

 

 

 

Synthesis

 

HDL

Hepatocytes

Endocytosis

Lysosomal

 

 

Lipid

 

 

 

 

 

 

 

 

 

 

 

 

 

receptor

 

 

LDL

LDL

lipases

Cholesterin

10.15

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Extra-

 

LDL

 

 

 

 

Plate

LDL

HDL

 

Receptor

 

 

 

hepatic cells

 

CHO-

 

 

 

 

 

receptor

 

 

 

 

 

 

 

 

LCAT

 

 

 

esters

ACAT

 

 

 

 

 

 

 

(Store)

 

 

 

 

 

 

 

 

 

 

 

contact

 

 

 

 

 

 

Membranes,

 

HDL

 

 

 

 

steroid synthesis

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liver

 

 

Synthesis

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liver

 

 

IDL

 

 

 

ca. 0.5g/day

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cholesterol

 

 

Bile salts

 

 

 

 

Chylom.

 

 

 

 

 

 

 

 

 

residue

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gut

Enterohepaticcirculation: ca. 24g/day

 

 

 

 

CHO-esters

 

Diet:

 

 

 

 

 

 

 

 

ca. 0.5g/day

 

 

LPL

 

 

 

 

 

Cholesterol

 

 

 

 

 

 

 

CHO-esters

 

 

 

 

 

 

Bile

 

 

 

LPL

 

 

 

 

 

 

 

 

 

 

Unspecific

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

carboxyl

 

 

 

 

 

 

Mucosa

 

esterase

 

 

 

 

 

 

 

 

 

 

 

 

VLDL

 

 

 

 

 

Cell

 

blood

 

 

 

 

 

 

 

 

 

 

 

ca. 1g/day

ACAT

 

replacement

 

 

 

 

 

 

 

Chylo-

 

 

 

 

venous

 

 

 

 

 

 

 

 

 

microns

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Blood

Intestinal

Synthesis

Stools:

 

 

Portal

255

 

lymph

ca. 0.5g/day each

 

Despopoulos, Color Atlas of Physiology © 2003 Thieme

All rights reserved. Usage subject to terms and conditions of license.

 

 

!

 

 

surface of TGs and VLDL activates LPL. The in-

 

 

sulin secreted after a meal induces LPL (!D),

 

 

which promotes the rapid degradation of reab-

 

 

sorbed dietary TGs. LPL is also activated by he-

 

 

parin (from endothelial tissue, mast cells, etc.),

 

 

which helps to eliminate the chylomicrons in

 

 

cloudy plasma; it therefore is called a clearance

 

 

factor. Albumin-complexed FFAs in plasma are

 

 

mainly transported to the following target

 

 

sites (!D):

 

 

Cardiac muscle, skeletal muscle, kidneys and

Digestion

 

other organs, where they are oxidized to CO2

 

and H2O in the mitochondria (! oxidation) and

 

 

used as a source of energy.

 

 

Fat cells (!D), which either store the FFAs

and

 

or use them to synthesize TG. When energy re-

 

quirements increase or intake decreases, the

 

 

Nutrition

 

FFAs are cleaved from triacylglycerol in the fat

 

stimulated by epinephrine, glucagon and corti-

 

 

cells (lipolysis) and transported to the area

 

 

where they are needed (!D). Lipolysis is

10

 

sol and inhibited by insulin (!p. 282ff.).

 

The liver, where the FFAs are oxidized or

 

 

 

 

used to synthesize TG.

 

 

Cholesterol (CHO)

 

 

 

 

Cholesterol esters (CHO-esters), like TGs, are

 

 

apolar lipids. In the watery milieu of the body,

 

 

they can only be transported when incor-

 

 

porated in lipoproteins (or bound to proteins)

 

 

and can be used for metabolism only after they

 

 

have been converted to CHO, which is more

 

 

polar (!B). CHO-esters serve as stores and in

 

 

some cases the transported form of CHO. CHO-

 

 

esters are present in all lipoproteins, but are

 

 

most abundant (42%) in LDL (!A).

 

 

Cholesterol is an important constituent of

 

 

cell membranes (!p. 14). Moreover, it is a pre-

 

 

cursor for bile salts (!B and p. 248), vitamin D

 

 

(!p. 292), and steroid hormones (!p. 294ff.).

 

 

Each day ca. 0.6 g of CHO is lost in the feces (re-

 

 

duced to coprosterol) and sloughed off skin.

 

 

The bile salt loss amounts to about 0.5 g/day.

 

 

These losses (minus the dietary CHO intake)

 

 

must be compensated for by continuous re-

 

 

synthesis of CHO in the intestinal tract and

 

 

liver (!B). CHO supplied by the diet is ab-

 

 

sorbed in part as such and in part in esterified

 

 

form (!B, lower right). Before it is reabsorbed,

256

 

CHO-esters are split by unspecific pancreatic

 

carboxylesterase to CHO, which is absorbed in

 

 

the upper part of the small intestine (!B, bottom). Mucosal cells contain an enzyme that re-esterifies part of the absorbed CHO: ACAT (acyl-CoA-cholesterol acyltransferase) so that both cholesterol and CHO-esters can be integrated in chylomicrons (!A). CHO and CHOesters in the chylomicron remnants (see above) are transported to the liver, where lysosomal acid lipases again break the CHO-esters down into CHO. This CHO and that taken up from other sources (LDL, HDL) leave the liver (!B): 1. by excretion into the bile (!p. 248), 2. by conversion into bile salts which also enter the bile (!p. 249 B), and 3. by incorporation into VLDL, the hepatic lipoprotein for export of lipids to other tissues. Under the influence of LPL (see above), the VLDL yield IDL and later LDL (!B, left). The LDL transport CHO and CHO-esters to cells with LDL receptors (hepatic and extrahepatic cells; !B, top). The receptor density on the cell surface is adjusted according to the prevailing CHO requirement. Like hepatic cells (see above) extrahepatic cells take up the LDL by receptor-mediated endocytosis, and lysosomal acid lipases reduce CHOesters to CHO (!B, top right). The cells can then insert the CHO in their cell membranes or use it for steroid synthesis. A cholesterol excess leads to (a) inhibition of CHO synthesis in the cells (3-HMG-CoA-reductase) and (b) activation of ACAT, an enzyme that esterifies and stores CHO in the form of its ester (see above).

Hyperlipoproteinemia. An excess of lipids in the blood can be reflected by elevation of triacylglycerol levels and/or CHO levels (!200–220 mg/dL serum; affects about one in five adults in Western countries). In the most severe form, familial hypercholesterolemia, a genetic defect causes elevated plasma CHO concentrations from birth on, which can result in myocardial infarction in juvenile age. The disease is caused by genetic defects of the high-affinity LDL receptors. The serum CHO level rises since the cells take up smaller quantities of cholesterol-rich LDLs. Extrahepatic tissues synthesize larger quantities of CHO because 3-HMG-CoA-reductase fails to inhibit CHO synthesis due to the decreased absorption of LDLs. As a result, more LDLs bind to the low-affinity scavenger receptors that mediate the storage of CHO in macrophages, cutaneous tissues, and blood vessels. Hypercholesterolemia therefore increases the risk of arteriosclerosis and coronary disease.

Despopoulos, Color Atlas of Physiology © 2003 Thieme

All rights reserved. Usage subject to terms and conditions of license.

C. Fat absorption

 

 

 

 

 

 

Fats

Micelle

 

 

 

Bile

Liver

 

 

Lipases

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Apolar lipids

 

II

 

Short-chain FFA

 

 

 

Bile salts

 

Storage

 

 

 

 

 

 

Intestinal lumen

 

 

 

 

 

Plate 10.16 Lipid Distribution and

 

Glucose

 

 

 

 

Enterohepatic circulation

 

MG

 

 

 

 

TG

 

 

 

 

 

TG

 

 

 

 

 

synthesis

Cholesterol

 

 

Mucosal cell in Ileum

 

 

 

 

 

 

CHO-esters

 

 

 

 

Phospholipids

 

 

 

Fat-soluble vitamins

Apolipoproteins

 

 

Jejunum

 

 

Chylomicrons

 

Lymph

 

To

 

 

 

 

 

(Cf. legends for Plate 10.14B)

systemic blood

 

 

Portal venous blood

 

 

 

 

 

 

 

 

D. Source and fate of triacylglycerols and free fatty acids

 

 

 

 

Intestine

Free fatty acids (FFA)

 

Intestinal lymph

 

Triacylglycerine (TG)

 

 

Diet

 

 

and

 

 

Glucose

 

monoacylglycerol

max. 15g/h

 

 

in micelles

 

 

 

FFA

Pancreatic

 

Energy metabolism

 

 

lipase

 

 

 

 

Liver

Pancreas

 

in VLDL

TG

 

TG

TG

 

 

 

 

 

 

 

 

Storage

 

 

 

4g/h

In chylo-

 

of excess fat

 

 

 

microns

 

Chylomicron

Insulin

 

 

max.

 

 

 

residues and IDL

 

 

 

 

 

 

 

 

 

LPL

 

 

 

 

 

 

 

 

 

Blood

 

FFA

 

 

 

 

Release from

 

 

 

 

 

 

stores 2–9g/h

 

 

 

 

 

 

 

TG

 

 

 

Energy metabolism

 

 

 

 

 

 

 

Epinephrine

 

Storage

 

 

in muscle, heart, etc.

 

 

 

 

 

 

257

Glucagon

 

 

 

 

 

Cortisol

 

in fat cells

 

 

 

 

 

 

 

 

 

 

 

 

Despopoulos, Color Atlas of Physiology © 2003 Thieme

All rights reserved. Usage subject to terms and conditions of license.

Digestion and Absorption of

Carbohydrates and Protein

 

Carbohydrates provide half to two-thirds of

 

the energy requirement (!p. 226). At least

 

50% of dietary carbohydrates consist of starch

 

(amylose and amylopectin), a polysaccharide;

 

other important dietary carbohydrates are

 

cane sugar (saccharose = sucrose) and milk

 

sugar (lactose). Carbohydrate digestion starts

 

in the mouth (!A1 and p. 236). Ptyalin, an α-

Digestion

amylase found in saliva, breaks starches down

into oligosaccharides (maltose, maltotriose, α

 

 

limit dextrins) in a neutral pH environment.

 

This digestive process continues in the proxi-

and

mal stomach, but is interrupted in the distal

stomach as the food is mixed with acidic gas-

 

Nutrition

tric juices. A pancreatic α-amylase, with a pH

continue to the final

oligosaccharide stage

 

optimum of 8 is mixed into the chyme in the

 

duodenum. Thus, polysaccharide digestion can

10

mentioned above. The carbohydrates can be

only absorbed in the form of monosaccharides.

 

 

Thus, the enzymes maltase and isomaltase in-

 

tegrated in the luminal brush border mem-

 

brane of enterocytes break down maltose, mal-

 

totriose and α limit dextrins into glucose as the

 

final

product.

As in

the renal

tubules

 

(!p. 158), glucose is first actively taken up by

 

the Na+ symport carrier SGLT1 into mucosal

 

cells (!A2, p. 29 B1) before passively diffusing

 

into the portal circulation via GLUT2, the glu-

 

cose

uniport

carrier

(facilitated

diffusion;

!p. 22). The hydrolysis of saccharose, lactose, and trehalose is catalyzed by other brush border enzymes: lactase, saccharase (sucrase) and trehalase. In addition to glucose, these reactions release galactose (from lactose), which is absorbed by the same carriers as glucose, and fructose, which crosses the enterocytes by passive uniporters, GLUT5 in the luminal and GLUT2 in the basolateral membrane (!A2).

Lactase deficiency. Lactose cannot be broken down and absorbed unless sufficient lactase is available. Lactase deficiencies lead to diarrhea 1) because water is retained in the intestinal lumen due to osmotic mechanisms, and 2) because intestinal bacteria convert the lactose into toxic substances.

Protein digestion starts in the stomach (!B1). 258 HCl in the stomach denatures proteins and converts the three secreted pepsinogens into

about eight different pepsins. At a pH of 2–5, these endopeptidases split off proteins at sites where tyrosine or phenylalanine molecules are incorporated in the peptide chain. The pepsins become inactive in the small intestine (pH 7–8). Pancreatic juice also contains proenzymes of other peptidases that are activated in the duodenum (!p. 246). The endopeptidases trypsin, chymotrypsin and elastase hydrolyze the protein molecules into short-chain peptides. Carboxypeptidase A and B (from the pancreas) as well as dipeptidases and aminopeptidase (brush border enzymes) act on proteins at the end of the peptide chain, breaking them down into tripeptides, dipeptides, and (mostly) individual amino acids. These cleavage products are absorbed in the duodenum and jejunum.

Amino acids (AA) are transported by a number of specific carriers (!B2) similar to those found in the kidneys (!p. 158). Neutral (without net charge) and anionic (“acid”) L- amino acids are transported with Na+ symporters (secondary active transport; !p. 28) from the intestinal lumen into mucosal cells, from which they passively diffuse with carriers into the blood. Cationic (“basic”) L-amino acids such as L-arginine+, L-lysine+ and L-or- nithine+ are partly taken up into the enterocytes by Na+ independent mechanisms, as the membrane potential is a driving force for their uptake. Anionic amino acids like L-glutamate and L-aspartate which, for the most part, are broken down in the mucosal cells, also have their own (Na+ and K+ dependent) carrier systems. Neutral amino acids use several different transporters.

AA absorption disorders can be congenital and affect various amino acid groups. These disorders are often associated with defects of renal tubular reabsorption (renal aminoaciduria, e.g. cystinuria).

Dipeptides and tripeptides can be absorbed as intact molecules by a symport carrier (PepT1). The carrier is driven by an H+ gradient (!B2), which in turn is generated by H+ secretion (tertiary active H+-peptide symport, !p. 29 B5). Amino acids generally are much more rapidly absorbed as dipeptides and tripeptides than as free amino acids. Once they enter the cells, the peptides are hydrolyzed to free amino acids.

Despopoulos, Color Atlas of Physiology © 2003 Thieme

All rights reserved. Usage subject to terms and conditions of license.

Соседние файлы в предмете [НЕСОРТИРОВАННОЕ]